Long-Term Effectiveness and Safety Evaluation of Arimoclomol Treatment in Patients With Niemann-Pick Disease Type C – Data From the Pivotal Study and Open-Label Extension
Friday, July 11, 2025 BiopharmaWatch Research 1 min read
Key Takeaway: The article discusses the long-term effectiveness and safety of Arimoclomol in patients with Niemann-Pick Disease Type C. Data from both the pivotal study and the open-label extension are highlighted, showcasing the treatment's positive outcomes. The findings were presented at the National Niemann Pick Disease Foundation Conference.
Price reaction · baseline $12.02 (2025-07-10 close) · hit pre-market · 1 other ZVRA headline(s) in the window, move may be shared
day 0 close · peak
+4.2%
Market Sentiment Analysis
POSITIVE FACTORS
Arimoclomol shows long-term effectiveness in treating Niemann-Pick Disease Type C.
Data from pivotal study indicates promising safety profile.
Open-label extension results support ongoing treatment benefits.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+71%
120-day peak, hindsight
Typical move
10.7%
average across 6 past catalysts
Lead asset
KP415
Phase 3 · ADHD
Full Press Release Details
< Medical Publications and Presentations
Long-Term Effectiveness and Safety Evaluation of Arimoclomol Treatment in Patients With Niemann-Pick Disease Type C – Data From the Pivotal Study and Open-Label Extension
National Niemann Pick Disease Foundation (NNPDF) Conference - 07/11/2025
Download PDF
Download PDF
Frequently Asked Questions
What is Arimoclomol used for?
Arimoclomol is used to treat Niemann-Pick Disease Type C.
What were the findings of the pivotal study?
The pivotal study showed long-term effectiveness and a promising safety profile for Arimoclomol.
Where was the data presented?
The data was presented at the National Niemann Pick Disease Foundation Conference.
What does the open-label extension indicate?
The open-label extension supports the ongoing benefits of Arimoclomol treatment.